Wandercraft a pour ambition de développer un exosquelette innovant, intuitif et facile d'utilisation, à destination des personnes à mobilité réduite
Location: France, Ile-of-France, Paris
Employees: 51-200
Phone: +33 9 72 58 77 05
Total raised: $45.38M
Founded date: 2012
Investors 5
Date | Name | Website |
- | LBO France | lbofrance.... |
- | Idinvest P... | idinvest.c... |
- | Wilco Acce... | wilco-star... |
- | Teampact.v... | teampact.v... |
- | XAnge Priv... | xange.fr |
Funding Rounds 1
Date | Series | Amount | Investors |
05.03.2022 | Series C | $45.38M | - |
Mentions in press and media 10
Date | Title | Description |
25.07.2024 | Para-Athlete Kevin Piette Wears AI-Powered Exoskeleton to Carry Olympic Flame | By Aldohn Domingo Published Jul 25, 2024 8:25AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket French tennis star, paraplegic Kevin Piette has reportedly donned an artificial inte... |
26.03.2024 | French biowearable startup Metyos raises €2.3M in pre-Seed funding: Know more | Read this article in: Paris-based Metyos, a medtech startup tackling chronic kidney disease (CKD), announced that it has secured €2.3M in a pre-seed round of funding. The investment was led by Cenitz with participation from KIMA Ventures, A... |
26.03.2024 | Metyos raises €2.3M pre-seed to combat chronic kidney disease | Paris based medtech startup Metyos has raised €2.3 million in pre-seed funding to develop biosensors for the 800 million people affected by chronic kidney disease (CKD). Metyos’ biosensors take the form of a small patch that sticks to the s... |
24.01.2023 | FDA Approves Wandercraft’s Atalante Exoskeleton For Stroke Rehabilitation | April Fowell, Tech Times 24 January 2023, 01:01 am The Food and Drug Administration (FDA) has approved Wandercraft's Atalante exoskeleton for stroke rehabilitation, as reported by Engadget. (Photo : CLAUDIO CRUZ/AFP via Getty Images) David ... |
21.01.2022 | France's Wandercraft closes $45M Series C | Healthtech startup Wandercraft has raised $45 million in Series C funding led by Quadrant Management. Bpifrance also participated in the round, as did investors including MACSF, Malakoff Humanis and AG2R La Mondiale. Paris-based Wandercraft... |
21.01.2022 | Wandercraft Closes $45 Million Series C Financing To Accelerate Delivery Of The World’s First Personal Self-Balanced Exoskeleton | A huge step towards mobility for all Wandercraft, a leading healthtech company in dynamic robotics and exoskeleton technology, announced a $45 million equity financing. The series C round was led by the US fund Quadrant Management, joined b... |
20.01.2022 | Paris-founded Wandercraft secures €40 million to accelerate delivery of its personal self-balanced exoskeleton | Pioneering healthtech startup, Wandercraft, has just announced €40 million of new funding to continue advancing dynamic robotics and exoskeleton technology. The series C round was led by the US fund Quadrant Management, joined by existing i... |
21.12.2021 | Увлекаетесь робототехникой? Представляем ведущих работодателей мира в этой области | Токио, Япония Токио — одно из лучших мест в мире для создания новых робототехнических разработок благодаря высококвалифицированным сотрудникам, впечатляющим университетам и большой клиентской базе. После пандемии в стране наблюдается всплес... |
- | Check out the 13-slide pitch deck Wandercraft, a startup that builds robots to help wheelchair users walk, used to raise $45 million | Wandercraft's exoskeleton has been used in rehab clinics since 2019. Wandercraft This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Wandercraft, an exoskeleton startup, just raised $45 milli... |
- | Living assistance robots now a reality as Wandercraft bags $45 million for world’s first personal Exoskeleton | How many of us remember Rosie the robot from The Jetsons? With four-fingered hands, an omnidirectional mobile base and a wide variety of sensors, she literally zoomed around the house doing all the domestic chores that humans hate to do. In... |